| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 12 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 3 | ETOPOSIDE | 12 |
| 4 | METHOTREXATE SODIUM | 10 |
| 5 | METHOTREXATE | 9 |
| 6 | CARBOPLATIN | 8 |
| 7 | THIOTEPA | 8 |
| 8 | BEVACIZUMAB | 6 |
| 9 | TOCILIZUMAB | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THYROTROPIN ALFA | 1 | 0.0010 |
| 1 | THIOTEPA | 8 | 0.0008 |
| 2 | ANTIHEMOPHILIC FACTOR HUMAN | 1 | 0.0007 |
| 3 | DONANEMAB-AZBT | 2 | 0.0007 |
| 4 | INSULIN ASPART INJECTION | 1 | 0.0004 |
| 5 | ZINC SULFATE INJECTION, | 1 | 0.0003 |
| 6 | ZINC SULFATE INJECTION | 1 | 0.0003 |
| 7 | DEFERIPRONE | 1 | 0.0003 |
| 8 | EDOXABAN TOSYLATE | 2 | 0.0003 |
| 9 | SCOPOLAMINE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 1 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 2 | Topoisomerase Inhibitor [EPC] | 12 | 0.0002 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Anticholinergic [EPC] | 1 | 0.0001 |
| 5 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 12 | 0.0000 |
| 7 | Progesterone [EPC] | 1 | 0.0000 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 5 | 0.0000 |
| 9 | Iron Chelator [EPC] | 1 | 0.0000 |